Skip to main content
. Author manuscript; available in PMC: 2023 Mar 1.
Published in final edited form as: Ann Thorac Surg. 2021 Apr 20;113(3):911–917. doi: 10.1016/j.athoracsur.2021.03.092

Table 2:

Random-effect Cox model with segmented linear splines for 1-year survival after lung transplantation (n = 9423).

Hazards ratio (95% CI) P value

Higher transplant volume (per case)*
 When <33 cases 0.989 (0.980 – 0.999) 0.036
 When ≥33 cases 1.000 (0.996 – 1.003) 0.798
Higher recipient age (per year) 1.016 (1.008 – 1.023) <0.001
Male recipient 1.105 (0.969 – 1.260) 0.137
Recipient ethnicity
 White Reference
 Black 1.270 (1.040 – 1.552) 0.019
 Others 1.020 (0.823 – 1.265) 0.856
Higher LAS (per unit) 1.006 (1.001 – 1.012) 0.027
Diagnosis grouping
 Restrictive lung disease Reference
 Obstructive lung disease 1.013 (0.859 – 1.196) 0.876
 Pulmonary vascular disease 1.424 (1.026 – 1.977) 0.035
 Cystic fibrosis 0.996 (0.733 – 1.352) 0.978
Medical acuity
 Not hospitalized Reference
 Hospitalized but not in ICU 0.958 (0.751 – 1.222) 0.732
 In ICU 1.012 (0.754 – 1.359) 0.935
Higher mean pulmonary artery pressure (per mmHg) 1.006 (1.000 – 1.012) 0.052
Higher creatinine (per unit) 1.078 (0.989 – 1.174) 0.088
Preoperative ventilator support 1.469 (1.088 – 1.985) 0.012
Preoperative ECMO support 1.119 (0.812 – 1.542) 0.493
Longer ischemic time (per hour) 1.070 (1.033 – 1.108) <0.001
Single lung transplant 1.067 (0.914 – 1.244) 0.413
Higher donor age (per year) 1.003 (0.999 – 1.008) 0.123
Donor non-heart beating 1.127 (0.819 – 1.551) 0.463
Higher donor PaO2/FiO2 (per 10 mmHg) 0.998 (0.993 – 1.003) 0.416
*

Two-segment linear splines.

Abbreviations: CI, confidence interval; ECMO, extracorporeal membrane oxygenation; ICU, intensive care unit; LAS, lung allocation score.